208 related articles for article (PubMed ID: 25990232)
1. Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013.
Pesola AK; Sihvonen R; Lindholm L; Pätäri-Sampo A
Euro Surveill; 2015 May; 20(18):. PubMed ID: 25990232
[TBL] [Abstract][Full Text] [Related]
2. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
3. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
4. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
[TBL] [Abstract][Full Text] [Related]
5. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
6. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.
Desjardins M; Delgaty KL; Ramotar K; Seetaram C; Toye B
J Clin Microbiol; 2004 Dec; 42(12):5620-3. PubMed ID: 15583291
[TBL] [Abstract][Full Text] [Related]
8. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China.
Zhou W; Jiang YM; Wang HJ; Kuang LH; Hu ZQ; Shi H; Shu M; Wa CM
Indian J Med Microbiol; 2014; 32(3):290-3. PubMed ID: 25008823
[TBL] [Abstract][Full Text] [Related]
10. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
[TBL] [Abstract][Full Text] [Related]
11. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
Chen I; Kaufisi P; Erdem G
J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
13. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
14. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
Alós JI; Aracil B; Oteo J; Gómez-Garcés JL;
J Antimicrob Chemother; 2003 Feb; 51(2):333-7. PubMed ID: 12562699
[TBL] [Abstract][Full Text] [Related]
15. Genetic and phenotypic characterization of resistance to macrolides in Streptococcus pyogenes from Argentina.
Martínez S; Amoroso AM; Famiglietti A; de Mier C; Vay C; Gutkind GO;
Int J Antimicrob Agents; 2004 Jan; 23(1):95-8. PubMed ID: 14732322
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013.
Smit PW; Lindholm L; Lyytikäinen O; Jalava J; Pätäri-Sampo A; Vuopio J
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2131-6. PubMed ID: 26292935
[TBL] [Abstract][Full Text] [Related]
17. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Muhtarova AA; Gergova RT; Mitov IG
J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
